Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 236

1.

Prognostic value role of radiofrequency lesion size by cardiac magnetic resonance imaging on outcomes of ablation in patients with ischemic scar-related ventricular tachycardia: A single center pilot study.

Guler TE, Yalin K, Aksu T, Golcuk E, Sanli S, Kaya Bilge A, Adalet K.

Medicine (Baltimore). 2018 Nov;97(46):e12955. doi: 10.1097/MD.0000000000012955.

2.

Platelet Inhibition to Target Reperfusion Injury (The PITRI trial): Rationale and Study Design.

Bulluck H, Chan M, Bryant J, Chai P, Chawla A, Chua T, Chung YC, Gao F, Ho HH, Ho AFW, Hoe AJ, Syed Saqib I, Lee R, Han LS, Liew BW, Yun PLZ, Hock MOE, Paradies V, Roe MT, Teo L, Wong A, Wong E, Wong P, Watson T, Chan MY, Tan JW, Hausenloy DJ.

Clin Cardiol. 2018 Nov 12. doi: 10.1002/clc.23110. [Epub ahead of print]

3.

Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.

Lemkes JS, Janssens GN, van der Hoeven NW, van de Ven PM, Marques KMJ, Nap A, van Leeuwen MAH, Appelman YEA, Knaapen P, Verouden NJW, Allaart CP, Brinckman SL, Saraber CE, Plomp KJ, Timmer JR, Kedhi E, Hermanides RS, Meuwissen M, Schaap J, van der Weerdt AP, van Rossum AC, Nijveldt R, van Royen N.

Eur Heart J. 2018 Oct 26. doi: 10.1093/eurheartj/ehy651. [Epub ahead of print]

PMID:
30371767
4.

Impact of Natural Mild Hypothermia in the Early Phase of ST-Elevation Myocardial Infarction: Cardiac Magnetic Resonance Imaging Study.

Lim K, Yang JH, Hahn JY, Choi SH, Gwon HC, Park SJ, Song YB.

J Cardiovasc Imaging. 2018 Sep;26(3):175-185. doi: 10.4250/jcvi.2018.26.e21. Epub 2018 Sep 20.

5.

Left ventricular blood flow kinetic energy after myocardial infarction - insights from 4D flow cardiovascular magnetic resonance.

Garg P, Crandon S, Swoboda PP, Fent GJ, Foley JRJ, Chew PG, Brown LAE, Vijayan S, Hassell MECJ, Nijveldt R, Bissell M, Elbaz MSM, Al-Mohammad A, Westenberg JJM, Greenwood JP, van der Geest RJ, Plein S, Dall'Armellina E.

J Cardiovasc Magn Reson. 2018 Aug 30;20(1):61. doi: 10.1186/s12968-018-0483-6.

6.

Characteristics of the ablation lesions in cardiac magnetic resonance imaging after radiofrequency ablation of ventricular arrhythmias in relation to the procedural success.

Dinov B, Oebel S, Hilbert S, Loebe S, Arya A, Bollmann A, Sommer P, Jahnke C, Paetsch I, Hindricks G.

Am Heart J. 2018 Oct;204:68-75. doi: 10.1016/j.ahj.2018.06.014. Epub 2018 Aug 2.

PMID:
30077835
7.

Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction.

Rossello X, Piñero A, Fernández-Jiménez R, Sánchez-González J, Pizarro G, Galán-Arriola C, Lobo-Gonzalez M, Vilchez JP, García-Prieto J, García-Ruiz JM, García-Álvarez A, Sanz-Rosa D, Ibanez B.

J Cardiovasc Transl Res. 2018 Aug;11(4):310-318. doi: 10.1007/s12265-018-9819-8. Epub 2018 Aug 2.

PMID:
30073540
8.
9.

Impact of chronic total occlusion in a non-infarct-related coronary artery on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction.

Saad M, Stiermaier T, Fuernau G, Pöss J, Desch S, Thiele H, Eitel I.

Int J Cardiol. 2018 Aug 15;265:251-255. doi: 10.1016/j.ijcard.2018.03.042.

PMID:
29885694
10.

Quantitative cardiovascular magnetic resonance: extracellular volume, native T1 and 18F-FDG PET/CMR imaging in patients after revascularized myocardial infarction and association with markers of myocardial damage and systemic inflammation.

Kunze KP, Dirschinger RJ, Kossmann H, Hanus F, Ibrahim T, Laugwitz KL, Schwaiger M, Rischpler C, Nekolla SG.

J Cardiovasc Magn Reson. 2018 May 24;20(1):33. doi: 10.1186/s12968-018-0454-y.

11.

Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI.

De Maria GL, Alkhalil M, Wolfrum M, Fahrni G, Borlotti A, Gaughran L, Dawkins S, Langrish JP, Lucking AJ, Choudhury RP, Porto I, Crea F, Dall'Armellina E, Channon KM, Kharbanda RK, Banning AP.

JACC Cardiovasc Imaging. 2018 Apr 14. pii: S1936-878X(18)30217-1. doi: 10.1016/j.jcmg.2018.02.018. [Epub ahead of print]

PMID:
29680355
12.

Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.

Engstrøm T, Nepper-Christensen L, Helqvist S, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Tilsted HH, Steensberg A, Fabricius S, Mouritzen U, Vejlstrup N, Ahtarovski KA, Göransson C, Bertelsen L, Kyhl K, Olivecrona G, Kelbæk H, Lassen JF, Køber L, Lønborg J.

Heart. 2018 Oct;104(19):1593-1599. doi: 10.1136/heartjnl-2017-312774. Epub 2018 Mar 30.

PMID:
29602883
13.

Quantitative and qualitative assessment of acute myocardial injury by CMR at multiple time points after acute myocardial infarction.

Symons R, Claus P, Marchi A, Dresselaers T, Bogaert J.

Int J Cardiol. 2018 May 15;259:43-46. doi: 10.1016/j.ijcard.2018.02.093. Epub 2018 Feb 25.

PMID:
29506936
14.

Prediction of infarct size and adverse cardiac outcomes by tissue tracking-cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction.

Yoon YE, Kang SH, Choi HM, Jeong S, Sung JM, Lee SE, Cho I, Cho GY, Chang HJ, Chun EJ.

Eur Radiol. 2018 Aug;28(8):3454-3463. doi: 10.1007/s00330-017-5296-8. Epub 2018 Feb 15.

PMID:
29450717
15.

Peak CK-MB has a strong association with chronic scar size and wall motion abnormalities after revascularized non-transmural myocardial infarction - a prospective CMR study.

Pöyhönen P, Kylmälä M, Vesterinen P, Kivistö S, Holmström M, Lauerma K, Väänänen H, Toivonen L, Hänninen H.

BMC Cardiovasc Disord. 2018 Feb 8;18(1):27. doi: 10.1186/s12872-018-0767-7.

16.

Advances in computational modelling for personalised medicine after myocardial infarction.

Mangion K, Gao H, Husmeier D, Luo X, Berry C.

Heart. 2018 Apr;104(7):550-557. doi: 10.1136/heartjnl-2017-311449. Epub 2017 Nov 10. Review.

PMID:
29127185
17.

MR Assessment of Acute Pathologic Process after Myocardial Infarction in a Permanent Ligation Mouse Model: Role of Magnetic Nanoparticle-Contrasted MRI.

Park C, Park EH, Kang J, Zaheer J, Lee HG, Lee CH, Chang K, Hong KS.

Contrast Media Mol Imaging. 2017 Oct 18;2017:2870802. doi: 10.1155/2017/2870802. eCollection 2017.

18.

A meta-analysis on the correlation between admission hyperglycemia and myocardial infarct size on CMRI.

Pak S, Yatsynovich Y, Markovic JP.

Hellenic J Cardiol. 2018 May - Jun;59(3):174-178. doi: 10.1016/j.hjc.2017.09.009. Epub 2017 Oct 10.

19.

Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories.

Klem I, Heiberg E, Van Assche L, Parker MA, Kim HW, Grizzard JD, Arheden H, Kim RJ.

J Cardiovasc Magn Reson. 2017 Aug 11;19(1):62. doi: 10.1186/s12968-017-0378-y.

20.

Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping.

Bulluck H, Hammond-Haley M, Fontana M, Knight DS, Sirker A, Herrey AS, Manisty C, Kellman P, Moon JC, Hausenloy DJ.

J Cardiovasc Magn Reson. 2017 Aug 1;19(1):57. doi: 10.1186/s12968-017-0370-6.

Supplemental Content

Loading ...
Support Center